MDMA is close to potential FDA approval as a treatment for PTSD. This has opened the door for scientists to discover and develop the next generation of entactogen compounds inspired by MDMA’s therapeutic effects. What are these molecules? What innovative strategy will it take to bring these transformative medicines to market? Leaders in funding and research will explore innovative strategies for financing the research and development path from discovery to approved therapies. They will explore the array of promising new molecules, who they are meant to support, and their applications for improving mental health.